RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies
-
- STATUS
- Recruiting
-
- sponsor
- The Rogosin Institute
Summary
RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies
Description
The purpose of this research bio-repository study is to collect demographic, clinical, biochemical, histological, and genetic (RNA) data and samples from a large population of subjects with a variety of renal disease states, including diabetic, inflammatory, autoimmune and transplant related renal conditions, in order to assess for factors that may be associated with the progression of disease, the incidence of complications, (including renal failure), and the responses to therapy. In addition, the bio-repository will include the collection of data and samples from control subjects without established renal disease.
This study will provide an opportunity to compare data from various disease states with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating non-invasive clinical and biological features that predict renal biopsy findings.
Potential Benefits: There is no guarantee that subjects will benefit personally from this study. Knowledge gained from RENAL AID may benefit subjects and others in the future.
For More Information Contact:
Nelson Chen, MA, Clinical Research Coordinator646-317-0785
nec9039@nyp.org
Details
| Condition | Kidney Disease |
|---|---|
| Clinical Study Identifier | TX150221 |
| Sponsor | The Rogosin Institute |
| Last Modified on | 25 March 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer